All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 135 of 206 pages ‹ First < 133 134 135 136 137 > Last ›
HSL3051
Baker D
Financing Drug Research: What Are the Issues?
Washington DC: Center for Economic and Policy Research 2004 Sep 21
http://www.cepr.net/index.php/publications/reports/financing-drug-research-what-are-the-issues/
HSL869
Drug Study Registries Raise Competitive Concerns (for Big Pharma)
Reuters 2004 Sep 20
HSL12691
Smoller JW.
The Etiology and Treatment of Childhood
New Media Explorer 2004 Sep 19
http://www.newmediaexplorer.org/emma_holister/2004/09/19/the_etiology_and_treatment_of.htm
HSL868
Tenpenny S.
Vaccines: An Online Conference: The Flu Season Campaign Begins
Redflagsdaily.com 2004 Sep 17
HSL20069
Marshal T
Hijacked by ads
Australian Doctor 2004 Sep 1719
HSL867
Tell Truth About Antidepressants: On drug labels and in medical journals
Newsday.com 2004 Sep 16
HSL866
For Honest Reports of Drug Trials
The New York Times 2004 Sep 11
HSL876
Meet the people shaping the future of science: Cures before cash
Interview New Scientist 2004 Sep 4
HSL20079
Sweeney C
Expert calls for advertising ban on prescribing software
Australian Doctor 2004 Sep 35
http://www.australiandoctor.com.au/news/latest-news/expert-calls-for-advertising-ban-on-prescribing-so
HSL865
Vranica S.
Drug Maker, Talent Agency Team Up to Place Product In Entertainment Venues
The Wall Street Journal 2004 Sep 2
HSL863
Miller H.
The Truth About Marcia Angell
Tech Central Station 2004 Sep 1
HSL864
Cassels A.
We can swing no-frills Pharmacare
Vancouver Sun 2004 Sep 1
HSL4449
Saunders C.
Program targets drug rep input.
Australian Doctor Weekly 2004 Sep 1
HSL5329
Elliott C.
Pharma goes to the laundry: Public relations and the business of medical education.
Hastings Cent Rep 2004 Sep-Oct 01;34:(5):18-23
HSL1790
Andrews E, Dombeck M.
The role of scientific evidence of risks and benefits in determining risk management policies for medications.
Pharmacoepidemiol Drug Saf 2004 Sep;13:(9):599-608
http://www3.interscience.wiley.com/cgi-bin/abstract/105560406/ABSTRACT
HSL2414
Donohue JM, Berndt ER.
Effects of Direct-to-Consumer Advertising on Medication Choice: The Case of Antidepressants
Journal of Public Policy & Marketing 2004 Fall;23:(2):115–127
http://www.kff.org/rxdrugs/upload/Effects-of-Direct-to-Consumer-Advertising-on-Medication-Choice-the-Case-of-Antidepressants.pdf
HSL4604
Oldani MJ.
Thick prescriptions: toward an interpretation of pharmaceutical sales practices.
Med Anthropol Q 2004 Sep;18:(3):325-56
HSL13270
Druss BG, Marcus SC, Olfson M, Pincus HA.
Listening to generic Prozac: winners, losers, and sideliners.
Health Aff (Millwood) 2004 Sep-Oct;23:(5):210-6
http://content.healthaffairs.org/cgi/content/full/23/5/210
HSL13302
Oldani MJ.
Thick prescriptions: toward an interpretation of pharmaceutical sales practices.
Med Anthropol Q 2004 Sep;18:(3):325-56
http://www.ncbi.nlm.nih.gov/pubmed/15484967
HSL13310
Vatjanapukka V, Waryszak R.
Relationship between consumer knowledge, prescription drug advertising exposure and attitudes towards direct-to-consumer prescription drug advertising
International Journal of Medical Marketing 2004 Sep;4:(4):350-360
http://www.ingentaconnect.com/content/pal/jmm/2004/00000004/00000004/art00010
HSL511
Martinez B.
Merck Dealt Setback by Zocor Study: In Cholesterol-Drug Battle, Large-Dose Regime Failed To Help High-Risk Patients
Wall Street Journal 2004 Aug 31
HSL509
Vergano D.
Scientists want research papers freely available
USA TODAY 2004 Aug 29
http://www.usatoday.com/news/science/2004-08-29-free-research_x.htm
HSL510
Day M.
Doctors' body accuses drug firms of 'disease mongering'
The Daily Telegraph 2004 Aug 29
HSL507
Mathews A.
Big HMO Reconsiders Vioxx After Study Points to Heart Risks
The Wall Street Journal 2004 Aug 26
HSL508
Quiggin J.
Labor must stand firm
Australian Financial Review 2004 Aug 26
HSL20001
Scherer FM
The Pharmaceutical Industry — Prices and Progress
NEJM 2004 Aug 26;351:927-932
http://www.nejm.org/doi/full/10.1056/NEJMhpr040117
HSL503
Pharmaceutical Drug Marketing Budgets Surpass $500 Million, Studies Show
PRNewswire 2004 Aug 25
HSL504
Allen L.
Gillard's $1bn plan for drugs
Australian Financial Review 2004 Aug 25
HSL505
Top U.S. Newspaper's Focous On Balance Skewed Coverage Of Global Warming, Analysis Reveals
2004 Aug 25
HSL502
Ipsos: Branded drug prices spurring non-compliance
Eyeforpharma 2004 Aug 24
HSL498
Roberts P.
Biota votes Australia best for research
Australian Financial Review 2004 Aug 23
HSL499
A marvel of modern medicine, and more
The Melbourne Age 2004 Aug 23
HSL500
Bremmer I.
To fight terrorism 'drug', US needs a demand-side strategy
The Australian 2004 Aug 23
HSL501
Bremmer .
To fight terrorism 'drug', US needs a demand-side strategy
The Australian 2004 Aug 23
HSL497
Gellene D.
'Mr. Botox' Case Raises Some Brows
LA Times 2004 Aug 22
HSL493
Mathews J, Thurbon E.
Bitter pill for an appendage state
2004 Aug 20
HSL494
Maine Inmate Sues OxyContin Maker
Join Together Online 2004 Aug 20
HSL496
Moss L.
Call to monitor drugs as antidepressants kill 500 people a year
Independent News 2004 Aug 20
HSL492
Angell M.
Drugmakers "Blackmail the Public"
Business Week 2004 Aug 18
HSL491
Harrison J.
OxyContin maker sued by state prison inmate
Bangor Daily News 2004 Aug 17
HSL19831
Simmonds HJ
Association of British Pharmaceutical Industry's code of practice needs to be clarified
BMJ 2004 Aug 14;329:(7462):404
http://www.bmj.com/content/329/7462/404.2.short
HSL20198
Rouse R
New Zealand voice raises risks of DTC advertising
Medical Observer 2004 Aug 145
HSL19841
Rouse R
New code seeks clearer promotion of drug benefits
Medical Observer 2004 Aug 13
HSL19956
Smith P
Drug compang ad rebunked by TGA
Australian Doctor 2004 Aug 133
http://www.australiandoctor.com.au/news/drug-company-ad-rebuked-by-tga
HSL979
Moyers B.
Media That Set Us Free
YES! Magazine 2004 Aug 11
HSL1607
Mansfield PR.
A 5 minute read re drug promotion: RCT
Poster presented at 8th World Congress on Clinical Pharmacology & Therapeutics (CPT2004) Brisbane 2004 Aug 1-6;
HSL4957
Phillips GC.
Medicolegal issues and ergogenic aids: trade, tragedy, and public safety, the example of ephedra and the Dietary Supplement Health and Education Act.
Curr Sports Med Rep 2004 Aug 01;3:(4):224-8
HSL9040
Halperin EC, Hutchison P, Barrier RC Jr.
A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
Int J Radiat Oncol Biol Phys 2004 Aug 1;59:(5):1477-83
http://linkinghub.elsevier.com/retrieve/pii/S0360301604002639
HSL1804
Reist D, Vandecreek L.
The pharmaceutical industry's use of gifts and educational events to influence prescription practices: Ethical dilemmas and implications for psychologists
Professional psychology-research and practice 2004 Aug;35:(4):329-335
HSL8662
Leading Clinician Calls for New Approach to Atopic Eczema Treatment at International Gathering of Patients’ Groups
World Allergy Organization 2004 Aug
http://web.archive.org/web/20070626193215/http://www.worldallergy.org/media/press_releases/atopic_eczema.html
HSL16363
Wilkinson JJ, Force RW, Cady PS.
Impact of safety warnings on drug utilization: marketplace life span of cisapride and troglitazone.
Pharmacotherapy 2004 Aug;24:(8):978-86
http://www.ncbi.nlm.nih.gov/pubmed/15338846
HSL20294
Margolis C, Jotkowitz A, Sitter H.
A problem solving and decision making toolbox for approaching clinical problems and decisions.
Inflamm Res 2004 Aug;53:
http://www.ncbi.nlm.nih.gov/pubmed/15338073
HSL19968
Robotham J
Drug maker accused of scare-mongering
The Sydney Morning Herald 2004 July 31
http://www.smh.com.au/small-business/drug-maker-accused-of-scaremongering-20090619-cpta.html
HSL19846
Rouse R
Call for GP use of drug samples to be reviewed
Medical Observer 2004 July 305
HSL506
California Pharmacies Sue Drug Makers, Allege Price Fixing
The Wall Street Journal 2004 Jul 26
HSL20029
McCrory G
Super Bribe Me now showing
Australian Doctor 2004 July 23 31
HSL495
Morais R.
Prozac Nation? Is the Party Over?
FORBES.com 2004 Jul 20
HSL121
Roehr B.
Stronger sanctions needed against companies that suppress data.
BMJ 2004 Jul 17;329:(7458):132
http://bmj.bmjjournals.com/cgi/content/full/329/7458/132
HSL1777
Centers for Disease Control and Prevention (CDC).
Genetic testing for breast and ovarian cancer susceptibility: evaluating direct-to-consumer marketing--Atlanta, Denver, Raleigh-Durham, and Seattle, 2003.
MMWR Morb Mortal Wkly Rep 2004 Jul 16;53:(27):603-6
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5327a1.htm
HSL1687
MacKinnon NJ.
Use of drug samples as a threat to seamless health care.
Am J Health Syst Pharm 2004 Jul 15;61:(14):1497-500
http://www.ajhp.org/cgi/reprint/61/14/1497.pdf
HSL122
Lenzer J.
Whistleblower charges medical oversight bureau with corruption.
BMJ 2004 Jul 10;329:(7457):69
http://bmj.bmjjournals.com/cgi/content/full/329/7457/69
HSL123
Herxheimer A.
Open access to industry's clinically relevant data: Urgently needed but when will we get it, and in what form
BMJ 2004 Jul 10;329:(7457):64-5
http://bmj.bmjjournals.com/cgi/content/full/329/7457/64
HSL4472
Henson L.
Ego overload.
Australian Doctor Weekly 2004 Jul 5
HSL19791
Charatan F
Drug marketing practices come under scrunity
BMJ 2004 July 3;329:(10):2
http://www.bmj.com/content/329/7456/10.2.full
HSL19792
Hopkins Tanne J
National Institutes of Health criticised for not preventing conflicts of interest
BMJ 2004 July 3;329:(7456):10
http://www.bmj.com/content/329/7456/10.2.full
HSL18035
Eaton L
GPs asked not to dmand payments from drg company representatives
BMJ 2004 July 1;329:(7457):72
http://www.bmj.com/cgi/content/full/329/7457/72-d
HSL2411
Daikos GK.
Ethical dilemmas encountered during clinical drug trials.
Int J Antimicrob Agents 2004 Jul;24:(1):24-31
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T7H-4CMHWSF-2&_coverDate=07%2F31%2F2004&_alid=309771980&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5059&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=a39ea5f611120e36cb595ba331e785fc
HSL2412
Romero CE, Baron JD, Knox AP, Hinchey JA, Ropper AH.
Barbiturate withdrawal following Internet purchase of Fioricet.
Arch Neurol 2004 Jul;61:(7):1111-2
http://archneur.ama-assn.org/cgi/content/full/61/7/1111
HSL2413
Frankenberger KA, Frankenberger WR, Peden BF, Hunt HL, Raschick CM, Steller EG, Peterson JA.
Effects of information on college students' perceptions of antidepressant medication.
J Am Coll Health 2004 Jul-Aug;53:(1):35-40
HSL4814
Pai SA.
Publication ethics policies for medical journals.
Indian J Med Ethics 2004 Jul-Sep;1:(3):93
HSL4815
Kamtekar R.
Why life-saving drugs should be public goals.
Indian J Med Ethics 2004 Jul-Sep;1:(3):77-8
HSL19389
Manchanda P, Chintagunta P
Responsiveness of physician prescription behaviour to salesforce effort: an individual level analysis
Market Lett 2004 July;15:(2):129-145
http://ideas.repec.org/a/kap/mktlet/v15y2004i2_3p129-145.html
HSL461
Reputations of Pharmaceutical and Health Insurance Companies Continue Their Downward Slide June 22, 2004
2004 Jun 30
HSL471
Letter to the Editor
Washington Post 2004 Jun 30
HSL472
Editorial: Missing Drug Data
The Washington Post 2004 Jun 30
HSL473
Evans R.
FoE joy as Bayer drops legal action
The Guardian 2004 Jun 30
HSL474
Pear R.
Investigators Say Drug Makers Repeatedly Overcharged
The New York Times 2004 Jun 30
HSL475
Hensley S.
Drug Firms Address Furor on Tests: New Guidance on Results Aims to Calm Concerns Over Negative Trial Data
The Wall Street Journal 2004 Jun 30
HSL476
Meier B.
Forest Asked to Supply Information on Marketing of Some Drugs
The New York Times 2004 Jun 30
HSL470
Wysocki B.
At Pitt, Scientists Decode The Secret of Getting Grants
The Wall Street Journal 2004 Jun 28
HSL459
Goozner M.
From The $800 Million Pill - Me Too!
Medscape 2004 Jun 27
HSL469
Fonda D.
Curbing The Drug Marketers - How a clampdown on pitching drugs for unapproved uses is changing the way Big Pharma operates
Time 2004 Jun 27
HSL215
Dodge , C .
Most U.S. Seniors Don't Know Medicare Bill Passed, Survey Shows
Bloomberg News 2004 Jun 26
HSL468
Meier B.
Drug Maker Acknowledges Some Negative Test Results
The New York Times 2004 Jun 26
HSL16749
Wolfe SM.
Dangers of rosuvastatin identified before and after FDA approval.
Lancet 2004 Jun 26;363:(9427):2189-90
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(04)16513-6
HSL466
Martinez B.
Big U.S. firms could reap windfall
The Globe and Mail 2004 Jun 25
HSL467
Whiting R.
Drugmakers Respond To Calls For Public Database Of Trials
InformationWeek 2004 Jun 25
HSL464
Metherell M.
Experts haggling over drug listing secrecy
Sydney Morning Hearld 2004 Jun 24
HSL465
PBS: where the real threat is
Sydney Morning Hearld 2004 Jun 24
HSL462
McGrath C.
Labor feels the heat over PBS backflip
The ABC 2004 Jun 23
HSL463
Meier B
Democrats Take a Look at Drug Tests
The New York Times 2004 Jun 23
HSL781
Bazell R.
Why are the new cancer drugs so expensive?
NBC News 2004 Jun 23
HSL458
Fox M.
Health Agency Proposes Ethics Crackdown
Reuters 2004 Jun 22
HSL460
Testimony to the Ways and Means Committee, U.S. House of Representatives US-Australia Free Trade Agreement: Implications for Prescription Drug Prices in the US and Australia
2004 Jun 22
HSL454
Frenkel J.
Clampdown on chemists to save $8b
The Herald Sun 2004 Jun 21
HSL455
Tragic teen suicides inspire idea that invites more
USA Today 2004 Jun 21
HSL456
Meier B.
A Medical Journal Quandary: How to Report on Drug Trials
The New York Times 2004 Jun 21
HSL457
Tuller D
Gentlemen, Start Your Engines?
T he New York Times 2004 Jun 21
HSL450
Dr. Kate
It's time to focus on information bias about drugs
Times Star 2004 Jun 20
HSL451
Scannel K.
It's time to focus on information bias about drugs
Times Star 2004 Jun 20
Page 135 of 206 pages ‹ First < 133 134 135 136 137 > Last ›
